{"code":"HSC","codeName":"Health and Safety Code","section":"121335","citation":"Health & Saf. Code, § 121335","status":"in-force","lawOn":"2026-09-28","headings":[{"name":"DIVISION 105. COMMUNICABLE DISEASE PREVENTION AND CONTROL [120100. - 122476.]","url":"https://blackletter.si/health-and-safety-code/division-105"},{"name":"PART 4. HUMAN IMMUNODEFICIENCY VIRUS (HIV) [120775. - 121349.3.]","url":"https://blackletter.si/health-and-safety-code/division-105/part-4"},{"name":"CHAPTER 14. Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial Grant Award for the Prevention of Maternal Transmission of Human Immunodeficiency Virus (HIV) Infection [121300. - 121335.]","url":"https://blackletter.si/health-and-safety-code/division-105/part-4/chapter-14"}],"history":"Added by Stats. 1995, Ch. 415, Sec. 7.   Effective January 1, 1996.","effective":"1996-01-01","html":"<p>It is the intent of the Legislature for the department to make every effort possible to insure a comprehensive and diverse expert representation on the committee. It is the intent of the Legislature to ensure that expert members of the committee include, but are not limited to, ethnic minorities and women.</p>","text":"It is the intent of the Legislature for the department to make every effort possible to insure a comprehensive and diverse expert representation on the committee. It is the intent of the Legislature to ensure that expert members of the committee include, but are not limited to, ethnic minorities and women.","otherVersions":[],"url":"https://blackletter.si/health-and-safety-code/acquired-immune-deficiency-syndrome-aids-clinical-trial-121335","source":"California Legislative Information bulk export (pubinfo)"}